SB-269970 hydrochloride
SIGMA/S7389 - powder, ≥98% (HPLC)
Synonym: (R)
CAS Number: 261901-57-9
Empirical Formula (Hill Notation): C18H28N2O3S · HCl
Molecular Weight: 388.95
MDL Number: MFCD03788020
Linear Formula: C18H28N2O3S · HCl
Product Type: Chemical
| assay | ≥98% (HPLC) |
| form | powder |
| InChI | 1S/C18H28N2O3S.ClH/c1-15- |
| InChI key | XQCJOYZLWFNDIO-PKLMIRHRSA |
| optical activity | [α]/D 75 to 90°, c = 1.0 in DMSO |
| Quality Level | 100 ![]() |
| SMILES string | Cl.CC1CCN(CC1)CC[C@H]2CCC |
| solubility | H2O: 10 mg/mL, clear (warmed to 60 °C) |
| storage condition | desiccated |
| storage temp. | 2-8°C |
| Application: | SB-269970 hydrochloride has been used to study the effect of different endotype combination on the activity of the 5-hydroxytryptamine receptor of tall fescue alkaloids. It has also been used to inhibit dopamine receptor signaling, in order to study its role in early hemocyte activation. |
| Application: | SB-269970 was used to study the role of 5-HT7 receptors in serotonin-induced hypothermia in rodents.6 |
| Biochem/physiol Actions: | SB-269970 is an anti-psychotic agent that shows high affinity for 5-HT7 receptors. It may be effective in treating cognitive disabilities and schizophrenia-like deficits.4 SB-269970 desensitizes and decreases the excitatory effects of 5-HT7 receptors in rat hippocampus.5 |
| Biochem/physiol Actions: | Selective 5-HT7 serotonin receptor antagonist. |
| Legal Information: | Sold with the permission of GlaxoSmithKline Pharmaceuticals |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

